Clavis proposes rights offering of units

Clavis Pharma ASA (OSE: CLAVIS), Oslo, Norway Business: Drug delivery, Cancer, Infectious Date announced: 9/4/13 Type: Rights offering of units To be raised: Up to NOK54 million ($8.8 million) Price p...